SEC Form 4 · accession 0001008310-15-000002
MYRIAD GENETICS INC · MYGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter D Meldrum
Officer — President & C.E.O. · Director
Period of report
Nov 3, 2014
Accepted (ET)
May 8, 2015 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000899923
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 3, 2014 | G | 6,000 | $0.00 | D | 540 | D | |
| Common Stock | May 6, 2015 | M | 5,555 | $18.00 | A | 10,424 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F1 | $18.00 | May 6, 2015 | M | 5,555 | D | — | Feb 23, 2021 | Common Stock | 5,555 | 0 | D |
Explanation of responses
- F1The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.